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A dynamic pharmacophore drives the interaction between psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a 
Introduction
It was recognized over 25 years ago that small diameter trigeminal neurons depolarize in response to mild decreases in pH (Krishtal and Pidoplichko, 1981) . However, acid-sensing ion channels (ASICs) were not discovered and recognized as neuronal proton sensors until 1997 (Waldmann et al., 1997) . ASICs are now thought to be a primary sensor of pain associated with local tissue acidosis resulting from (patho)physiological conditions such as inflammation, ischemia, infection, physical trauma, and tumors (Sluka et al., 2009) .
ASICs belong to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily of ion channels, which have the same overall topology and selectivity for transporting sodium (Kellenberger and Schild, 2002) . However, ASICs are distinguished by their restriction to chordates, their predominantly neuronal distribution, and their activation by a decrease in extracellular pH (Gründer and Chen, 2010) . There are four ASIC subtypes (ASIC1, ASIC2, ASIC3 and ASIC4), encoded by four distinct genes, with two of these having alternatively spliced forms (ASIC1a/ASIC1b and ASIC2a/ASIC2b). Functional ASIC channels consist of homo-or heterotrimeric assemblies of these subunits (Jasti et al., 2007; Carnally et al., 2008) , each with unique pH sensitivities and kinetics (Hesselager et al., 2004) .
ASIC1a is the most abundant ASIC subunit in the central nervous system and along with ASIC3 it has the highest affinity for protons (Gründer and Chen, 2010) . Homomeric ASIC1a channels activate at pH 6.9 and the current amplitude increases as the proton concentration increases down to pH 6.0 (Gründer and Chen, 2010) . Various studies support a role for ASIC1a in mediating both inflammatory and neuropathic pain, and PPC-5650, a selective antagonist of ASIC1a, reduces thermal and mechanical hyperalgesia in a human inflammatory pain model (Dube et al., 2009 ). In addition, ASIC1a appears to play an important role in fear conditioning, epileptic seizure termination, autoimmune disease, and ischemia-induced neurodegeneration (Xiong et al., 2008; Dube et al., 2009; Sluka et al., 2009; Gründer and Chen, 2010) . Thus, ASIC1a has been touted as a novel therapeutic target for a broad range of pathophysiological conditions including pain, ischemic stroke, depression and autoimmune diseases (Xiong et al., 2008; Dube et al., 2009; Sluka et al., 2009; Gründer and Chen, 2010) .
Several small molecule ASIC1a blockers have been reported, but they are mostly weak and non-selective. The diuretic drug amiloride blocks all ASIC subtypes with moderate potency (IC 50 ~10-50 μM), while several non-steroidal anti-inflammatory drugs such as ibuprofen weakly inhibit ASIC1a (IC 50 ~350 μM) (Xiong et al., 2008) . Anti-protozoal diarylamidines also non-selectively block ASICs with low micromolar potency . The most potent and selective blocker of ASIC1a is psalmotoxin-1 (PcTx1) a 40-residue peptide isolated from the venom of the tarantula Psalmopoeus cambridgei. PcTx1 (hereafter called π-theraphotoxin-Pc1a (π-TRTX-Pc1a) based on the rational nomenclature for naming peptide toxins (King et al., 2008) ) inhibits ASIC1a channels with an IC 50 of ~1 nM, but does not block other ASIC subtypes at concentrations up to 50 nM (Escoubas et al., 2000) . At higher concentrations (EC 50 ~100-140 nM) π-TRTX-Pc1a also positively modulates rat ASIC1b (Chen et al., 2006) . π-TRTX-Pc1a is an effective analgesic, comparable to morphine, in rodent models of acute pain (Mazzuca et al., 2007) and intranasal administration of π-TRTXPc1a provided neuroprotection in a mouse model of ischemic stroke, even when administered hours after injury (Pignataro et al., 2007) .
A low-resolution solution structure of π-TRTX-Pc1a was determined previously and the channel interaction surface was proposed to reside in a highly cationic β-hairpin loop (Escoubas et al., 2003) . In two recent studies (Pietra, 2009; Qadri et al., 2009) , this structure This article has not been copyedited and formatted. The final version may differ from this version. of π-TRTX-Pc1a was docked onto a homology model of human ASIC1a and, in both cases, the toxin was found to interact with the acidic pocket on the channel ectodomain that plays a critical role in proton binding. However, the toxin orientation differs between the two models, and the precise molecular details of the toxin:channel interaction remain uncertain.
In order to provide a better understanding of the mechanism of action of π-TRTX-Pc1a, we developed a bacterial expression system for producing π-TRTX-Pc1a mutants for functional analysis and isotopically labeled protein for determination of a high quality structure.
Mutagenesis studies, in combination with NMR relaxation data and molecular dynamics simulations, revealed that the key pharmacophore residues are located in a β-hairpin loop that undergoes significant motion in solution. Experimental restraints were used to dock our new high-resolution structure of π-TRTX-Pc1a onto ASIC1a. The resulting model of the π-TRTXPc1a:ASIC1a complex differs substantially from previously published models and it offers new insights into the mechanism by which π-TRTX-Pc1a modulates the activity of ASIC1a.
Materials and Methods

Production of recombinant π-TRTX-Pc1a
A synthetic gene encoding π-TRTX-Pc1a, or point mutants thereof, with codons optimized for expression in Escherichia coli, was cloned into a variant of the pLic-MBP expression vector expression (Cabrita et al., 2006) . This vector encodes a MalE signal sequence for periplasmic export, a His 6 affinity tag, a maltose binding protein (MBP) fusion tag (to aid solubility), and a tobacco etch virus (TEV) protease recognition site directly preceding the π-TRTX-Pc1a gene (Fig. 1A ). Plasmids were transformed into E. coli strain BL21(λDE3) for recombinant toxin production.
MALDI-TOF Mass Spectrometry
Toxin masses were confirmed by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) using a Model 4700 Proteomics Bioanalyser (Applied Biosystems, CA, USA). rpHPLC fractions were mixed (1:1, v:v) with α-cyano-4-hydroxycinnamic acid matrix (5 mg/ml in 50/50 acetonitrile/H 2 O) and MALDI-TOF spectra were collected in positive reflector mode. All masses given are for the monoisotopic M+H + ions.
Electrophysiological measurements
Toxin activity was assessed using two-electrode voltage-clamp (TEVC) experiments performed on Xenopus laevis oocytes expressing homomeric rat ASIC channels. Oocyte preparation, cRNA injection, and electrophysiology were performed as described (Jensen et al., 2009) . Briefly, oocytes were injected with rat ASIC1a (0.25 ng), ASIC1b (1 ng), ASIC2a
(2 ng) or ASIC3 (2.5 ng) cRNA, and experiments performed at room temperature (21-22°C) 2-5 days after cRNA injection. Oocytes were clamped at -60 mV (Warner OC-725C oocyte clamp; Warner Instruments, CT, USA) using two standard glass microelectrodes (0.5-2 MΩ) filled with 3 mM KCl solution. Data acquisition and analysis were performed using pCLAMP software, Version 8 (Axon Instruments, CA, USA). Currents were elicited by a drop in pH from 7.45 to 6.0 every 60 s using a microperfusion system to allow rapid solution exchange.
Serial dilutions of π-TRTX-Pc1a (from 10 pM to 30 nM) were administered post-stimulation at pH 7.45 and oocytes were bathed in the toxin solution until the next round of stimulation.
The effect of native and mutant π-TRTX-Pc1a on steady-state desensitization of rASIC1a was determined by applying twice the determined IC 50 for each peptide at various conditioning pH values from 7.60 to 7.00 for 120 s prior to stimulation by a pH drop to 6.0. All experiments were performed using ND96 solution spiked with 0.1% BSA in order to minimize adsorption of π-TRTX-Pc1a to plastic tubing. Statistics were performed using Prism 5.0c for Mac OS X.
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Structure determination
Lyophilized recombinant π-TRTX-Pc1a was resuspended at a final concentration of 300 μM in 10 mM sodium phosphate buffer, pH 6.0 constituted in either 92.5% H 2 O/7.5% D 2 O or 100% D 2 O. The sample was filtered using a low-protein-binding Ultrafree-MC centrifugal filter (0.22 um pore size; Millipore, MA, USA), then 300 μL was added to a susceptibilitymatched 5 mm outer-diameter microtube (Shigemi Inc., Japan).
Data were acquired at 298 K using a 900 MHz NMR spectrometer (Bruker BioSpin, Germany) equipped with a cryogenically cooled probe. Data for resonance assignments were acquired using non-uniform sampling (NUS). Sampling schedules that approximated the signal decay in each indirect dimension were generated using sched3D (Mobli et al., 2010) .
Pulse programs were modified from the standard Bruker library for NUS mode and are available from the authors upon request. NUS data were processed using the Rowland NMR toolkit (www.rowland.org/rnmrtk/toolkit.html) and maximum entropy parameters were automatically selected as previously described (Mobli et al., 2007) .
13 C-and 15 N-edited HSQC-NOESY (mixing time of 250 ms), HNHB, and long-range HNCO experiments were acquired using uniform sampling. All experiments were acquired in H 2 O except for the 13 C-edited HSQC-NOESY, which was acquired in D 2 O.
Dihedral-angles (20 φ, 22 ψ) were derived from TALOS chemical shift analysis (Cornilescu et al., 1999) , and the restraint range for structure calculations was set to twice the estimated standard deviation. Eight additional φ restraints of -105 ± 75˚ were applied for residues for which the intraresidue H α -H N NOE was clearly weaker than that between the H N and H α of the preceding residue (Fletcher et al., 1997) . All three X-Pro peptide bonds were identified as This article has not been copyedited and formatted. The final version may differ from this version. Hydrogen-bonds were identified by acquiring a long-range HNCO experiment, and by using preliminary structures to identify the hydrogen-bond acceptor for slowly-exchanging amide protons identified by their presence in the 13 C-edited NOESY-HSQC spectrum acquired days after reconstitution of the lyophilized protein in D 2 O. Hydrogen-bond and disulfide-bond restraints were applied as described previously (Fletcher et al., 1997) .
NOESY spectra were manually peak picked and integrated, then peaklists were automatically assigned, distance restraints extracted, and an ensemble of structures calculated using the torsion angle dynamics package CYANA (Güntert, 2004 
R 2 relaxation dispersion data analysis
15 N R 2 relaxation rates were measured at 298 K using single-scan interleaved constant time CPMG pulse sequences using a delay of 0.08 s (T CPMG ) on a Bruker 600 MHz spectrometer.
Relaxation dispersion profiles were produced by recording spectra with varying CPMG field strengths (25, 2 × 50, 75, 100, 2 × 150, 2 × 200, 300, 500, 600, 700, 900, 1000, 1500 and 2000 Hz). A reference spectrum without a CPMG pulse train was also recorded. Data fitting, model selection, and simulation were performed using the software NESSY (www.nessy.biochem.unimelb.edu.au).
Molecular dynamics simulations of π-TRTX-Pc1a
MD simulations of π-TRTX-Pc1a in explicit water were performed using GROMACS version 3.3.1 (van der Spoel et al., 2005) in conjunction with the GROMOS 53a6 force field (Oostenbrink et al., 2004) . The starting structure for simulations was the first model from the ensemble of π-TRTX-Pc1a structures determined in the current study. The protonation states This article has not been copyedited and formatted. The final version may differ from this version. of ionizable sidechains were set to pH 6.0, the pH at which the structure was determined and at which ASIC1a is activated under physiological conditions. The His14 residue in π-TRTX-Pc1a could be positively charged or neutral at pH 6.0 and therefore two systems were simulated. In system 1 both the Nδ and Nε of His14 were protonated (His14 positively charged). In system 2 only the Nε was protonated (His14 neutral). As the experimental NMR studies were performed at low salt concentration, systems 1 and 2 were simulated in the absence of counter ions. Each system was simulated for 2 × 5 ns (four simulations in total)
using an integration time-step of 2 fs. Further details of the simulation parameters are provided in Supplemental Data. Order parameters were calculated from the simulations using:
where μ α (α = 1, 2, 3) are the x, y, and z components of the normalized interatomic vector in the molecular frame. In the experiment, the timeframe probed by S 2 is dependent on the rotational correlation time of the molecule. Given that the length of the trajectories is insufficient to average over the rotational degrees of freedom, the correlation functions and order parameters were calculated after a least-squares fit on the backbone atoms (i.e., C α , C', and N). To correct for bias introduced using this approach the trajectory was analyzed by averaging the values over 100, 200 and 500-ps windows.
Construction of a homology model of rat ASIC1a
Homology modelling was performed using Modeller 9v2 (Eswar et al., 2006) . The 1.9 Å resolution crystal structure of chicken ASIC1 (cASIC1) (2QTS; Jasti et al., 2007) was used as a template for the extracellular domain (ECD) of rat ASIC1a (rASIC1a), whereas the 3 Å resolution structure of a more complete cASIC1 construct (3HGC; Gonzales et al., 2009) ). An initial model based on sequence similarity was refined based on predicted secondary structure. The ECD and TM regions were modelled individually, combined in one PDB file, then the chain break was fixed using Swiss PDB Viewer. Each subunit of the channel was modelled separately then combined to create a single PDB file containing coordinates for the complete trimer.
Protonation states for the channel were set to mimic pH 7 based on the pK a values of Glu, Asp, and His residues calculated previously for ASIC1a (Liechti et al., 2010) ; Glu and Asp residues with a pK a > 7 were protonated in the model, while all His residues were deprotonated. The model was energy minimized in water using GROMACS 3.3.1. Water was then removed from the PDB file and poor rotamers were adjusted in Swiss PDB Viewer.
Model quality was monitored using MolProbity (Davis et al., 2007) .
Modelling the π-TRTX-Pc1a:ASIC1a complex HADDOCK v2.1 (Dominguez et al., 2003) was used for docking studies as it allows incorporation of experimentally-derived information about residue flexibility and interaction surfaces. Residues W24, R26 and R27 of π-TRTX-Pc1a were defined as "active" ambiguous interactions restraints (AIRs) based on mutagenesis experiments described here. Toxin residues 24-29 were allowed to be flexible during docking based on the solution dynamics observed in NMR relaxation/dispersion experiments and MD simulations. In addition, unambiguous distance restraints were included for the disulfide bridges and hydrogen bonds in the toxin. All 25 models from the ensemble of π-TRTX-Pc1a structures were used for cross-docking against rASIC1a. Prior to docking, the protonation states of π-TRTX-Pc1a
residues were set to mimic pH 7, with all Asp, Glu and His residues deprotonated, as this is the optimal pH for binding of π-TRTX-Pc1a to ASIC1a (Salinas et al., 2006) . This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Production of recombinant π-TRTX-Pc1a
Recombinant π-TRTX-Pc1a was produced previously using a Drosophila expression system (Escoubas et al., 2003) but we explored the possibility of using E. coli as a more cost and time effective method. Venom toxins generally pose a challenge for recombinant expression due to the presence of multiple disulfide bonds, which cannot be formed within the cytoplasm of most cells due to the reducing environment (Tedford et al., 2001) . In order to obviate this problem, we used an IPTG-inducible construct ( Fig. 1A ) that allowed an MBP-toxin fusion protein to be exported to the E. coli periplasm, where the cell's disulfide-bond processing machinery is located (Tedford et al., 2001) . A TEV protease cleavage site between the MBP and toxin coding regions allowed facile removal of the MBP tag.
Using this system, π-TRTX-Pc1a was the major cellular protein produced after IPTG induction ( Fig. 1B ) and the toxin could be purified to >98% homogeneity (as judged by SDS-PAGE, HPLC, and MS) using a combination of nickel affinity chromatography and rpHPLC (Fig. 1C ). This bacterial expression system produces ~6 mg of correctly folded π-TRTX-Pc1a
per litre of culture, a significant improvement over the 0.5 mg/litre obtained using the previously published Drosophila expression system (Escoubas et al., 2003) . The recombinant toxin blocked ASIC1a currents in Xenopus oocytes with an IC 50 of 0.42 ± 0.05 nM ( Fig. 2A,B) , which compares well with the previously published value of 0.9 nM (Escoubas et al., 2000) . As previously reported for the native toxin, recombinant π-TRTX-Pc1a had no inhibitory effect on ASIC1b, ASIC2a and ASIC3 currents in Xenopus oocytes at This article has not been copyedited and formatted. The final version may differ from this version. concentrations up to 30 nM (data not shown).
Determination of a high-resolution solution structure of π-TRTX-Pc1a
The development of an efficient bacterial expression system allowed us to produce uniformly is shown in Supplementary Fig. S1 , and complete chemical shift assignments have been deposited in BioMagResBank (accession number 16468).
Multiple hydrogen-bonds involving backbone amide protons were identified from a longrange HNCO experiment, which has the advantage over hydrogen-deuterium exchange experiments of unambiguously identifying the hydrogen-bond acceptor. Fig. 3 shows a selected region from the long-range HNCO spectrum in which several hydrogen bonds can be directly observed.
CYANA was used for automated NOESY assignment and structure calculation. 300 structures were calculated from random starting conformations, then the 25 conformers with highest stereochemical quality as judged by MolProbity (Davis et al., 2007) were selected to represent the solution structure of π-TRTX-Pc1a. Coordinates for the final ensemble of This article has not been copyedited and formatted. The final version may differ from this version. Table 1 compares the precision and stereochemical quality of the π-TRTX-Pc1a structure determined in the current study with the previously published structure determined using only homonuclear NMR data (PDB accession number 1LMM). The average MolProbity score of 1.69 places the new ensemble of 25 structures in the 89th percentile relative to all other structures ranked by MolProbity whereas the original ensemble ranks in the 4th percentile with an average MolProbity score of 3.85. The higher overall stereochemical quality of the new ensemble stems from a much lower clashscore (a measure of bad close contacts), higher
Ramachandran plot quality, and more favourable sidechain rotamers (summarized in Table 1 ).
The new π-TRTX-Pc1a structure (Fig. 4A ) is more precisely determined than the original ensemble (backbone rmsd of 0.25 ± 0.05 Å over residues D2-K36 compared with 1.00 ± 0.21 Å for the previous ensemble; Escoubas et al., 2003) due to the higher density of experimental restraints used in the structure calculations (summarized in Table 1 ). As demonstrated previously (Escoubas et al., 2003) , the structure contains an inhibitor cystine knot motif (Pallaghy et al., 1994) in which the C17-C33 disulfide bond pierces a 14-residue ring formed by the other two disulfides and the intervening sections of the polypeptide backbone (Fig. 4C) . Thus, π-TRTX-Pc1a comprises four intercystine loops (numbered 1-4 in Fig. 4A ) bounded by N-and C-terminal "tails". The dominant secondary structure feature is a β hairpin (residues 21-35) comprising β strands 1 (L21-W24) and 2 (V32-K35) (Fig. 4) .
Despite the significantly higher precision of the new ensemble, it is largely contained within the bundle of previously determined π-TRTX-Pc1a structures (Fig. 4B) . Importantly, however, the higher precision of the new π-TRTX-Pc1a ensemble allows additional structural This article has not been copyedited and formatted. The final version may differ from this version. features to be recognized. Residues H14-D16 within loop 2 form a single turn of 3 10 helix that is not apparent in the original structure, in which this region is poorly defined, and residues C18-L21 at the outer edge of loop 3 form a well-defined β turn (Fig. 4A,C) . Loops 1 and 4 are also much better defined than in the original ensemble (see Fig. 4B ).
Definition of pharmacophore residues
The marked electrostatic anisotropy of π-TRTX-Pc1a, in which a strong dipole moment emerges from the highly basic patch of Arg and Lys residues at the tip of loop 4 (residues 24 to 32), led to the suggestion that this hairpin loop is the functional surface of π-TRTX-Pc1a, with the dipole moment being used to orient the toxin in the electric field of the ASIC1a channel (Escoubas et al., 2003) . Subsequent docking studies have lent credence to this proposal (Pietra, 2009; Qadri et al., 2009) . We decided to experimentally test this hypothesis by using the newly developed bacterial expression system to produce recombinant versions of π-TRTX-Pc1a in which residues in the β-hairpin loop were mutated to alanine. Specifically, we tested the ability of W24A, K25A, R26A, and R27A mutants to block ASIC1a (see Fig. 2C ). The activity of a H14A mutant was also examined, since this residue lies adjacent to the β-hairpin loop and contributes to the electrostatic anisotropy of π-TRTX-Pc1a. Natural abundance 1 H-15 N HSQC spectra of the mutants were used to confirm that these point mutations did not perturb the toxin structure (data not shown).
Based on the initial structure determination, K25 was predicted to be involved in the interaction with ASIC1a (Escoubas et al., 2003) and this hypothesis appeared to be confirmed by two published models of the toxin-ASIC1a complex (Pietra, 2009; Qadri et al., 2009) .
Surprisingly, we found that the K25A mutant was almost equipotent with the wild type toxin in blocking ASIC1a (IC 50 of 1.19 nM versus 0.44 nM for wild-type toxin) (Fig. 2C) . Thus, we
This article has not been copyedited and formatted. The final version may differ from this version. conclude that K25 is not essential for the interaction of π-TRTX-Pc1a with ASIC1a and probably makes few, if any, energetically favorable contacts with the channel. In contrast, mutation of both W24 and R27 to Ala caused a profound diminution in the ability of π-TRTX-Pc1a to block ASIC1a, with both mutations resulting in an ~150-fold increase in the IC 50 (Fig. 2C) . We conclude that both residues are critical for the interaction of π-TRTX-Pc1a
with ASIC1a. Curiously, the R26A mutant was completely ineffective at blocking ASIC1a but, at high concentrations (>100 nM), it behaved as a positive modulator, increasing the size of the ASIC1a currents beyond control stimulations. We therefore conclude that R26 forms part of the π-TRTX-Pc1a pharmacophore. The H14A mutant was equipotent with wild type toxin in blocking ASIC1a (IC 50 of 0.25 nM versus 0.44 nM for wild-type toxin; Fig. 2C ),
suggesting that the toxin pharmacophore is restricted to residues in the β-hairpin loop.
Since π-TRTX-Pc1a inhibits ASIC1a by shifting its steady-state desensitization to more alkaline pH, we investigated whether the mutations altered the functional effects of the toxin in addition to affecting its binding. All the mutants tested promoted an alkaline shift in steady-state desensitization similar to that caused by the wild-type peptide (see Table 3 and Supplementary Fig. 2 ). These results suggest that the observed changes in efficacy are likely due to a change in toxin binding affinity as opposed to an altered effect on channel gating. As expected, the R26A mutant did not cause a substantial alkaline shift in the SSD curve but it did shift the pH-dependence of activation to more alkaline values.
Structure and dynamics of the channel-binding loop
Since the mutagenesis studies described above revealed that the pharmacophore of π-TRTX-Pc1a is most likely confined to the β-hairpin loop, we were particularly interested in the orientation of sidechains within this loop as they were poorly defined in the original (Fig. 6 ).
As expected from the new ensemble of structures, the N-and C-termini of the toxin have the lowest order parameters, and these regions are presumed to be extremely flexible in solution.
There were only two other regions with S 2 <0.7, namely residues 15-16 in loop 2 and residues This article has not been copyedited and formatted. The final version may differ from this version. 25-30 in loop 4 (see Fig. 6 ), a result that is consistent with the disorder associated with loop 4 sidechains in the calculated ensemble of structures.
We next examined the backbone dynamics of π-TRTX-Pc1a using NMR spin relaxation and relaxation dispersion measurements and compared this with the dynamics predicted by MD simulations. The order parameter S 2 , which is indicative of motions on the ps to ns timescale, and the chemical/conformational exchange rate R ex , which is indicative of motions on the low μs timescale, were determined from model-free analysis of the 15 N longitudinal relaxation rate (R 1 ), transverse relaxation rate (R 2 ) and steady state { 1 H}-15 N NOE data (see Supplementary   Fig. S3 ). For most residues, the S 2 values calculated from the MD simulations and NMR relaxation data are in good agreement (see comparison in Fig. 6 ). The NMR data revealed ps-ns scale motions for most residues in π-TRTX-Pc1a with particularly low S 2 values for residues at the N-and C-termini as well as residue 14 in loop 2 and residues 26-27 in loop 4 (Fig. 7A , top panel; also see Supplementary Table S2 ). Additionally, the spin relaxation experiments yielded significant R ex values for most residues in loop 4, indicative of motion on the low μs time scale (Fig. 7A, bottom panel) .
To confirm the suspected motion in loop 4 over the μs-ms timescale, we performed R 2 relaxation dispersion experiments which are better suited than spin relaxation experiments for examining motion on this timescale. Analysis of the relaxation dispersion data revealed significant motion on the μs-ms timescale in loop 2 (residues 8 and 12) and loop 4 (residues 25 and 30) ( Fig. 7B ; also see Supplementary Table S3) . We therefore conclude, as summarized schematically in Fig. 7C , that prior to binding ASIC1a, the pharmacophorecontaining loop 4 of π-TRTX-Pc1a undergoes significant motion over a wide range of timescales. This motion clearly limits the utility of rigid-body docking approaches for This article has not been copyedited and formatted. The final version may differ from this version. modelling the π-TRTX-Pc1a:ASIC1a complex.
Modelling the π-TRTX-Pc1a:ASIC1a interaction
In order to perform restraints-based docking of π-TRTX-Pc1a and ASIC1a, we initially built a homology model of rat ASIC1a. Although models of human ASIC1a were used in previous docking studies (Pietra, 2009; Qadri et al., 2009) , we chose instead to use rASIC1a as the experimentally-derived docking restraints were derived from TEVC experiments on this channel and because π-TRTX-Pc1a binds less avidly to human ASIC1a (data not shown). The ECD of rASIC1a was modeled from the 1.9 Å resolution structure of a nonfunctional cASIC1
construct in which most of the cytoplasmic regions of the channel had been removed (Jasti et al., 2007) , leading to a non-physiological orientation for the TM helices (Gonzales et al., 2009 ). Thus, the TM regions were instead modeled from a lower resolution structure of a functional cASIC1 construct in which inclusion of more cytoplasmic regions led to a different orientation of the TM helices that is considered more representative of the in vivo state of the channel based on comparisons with the corresponding region of the P2X 4 receptor (Gonzales et al., 2009) . The structure of the ECD in the rASIC1a model was very similar to that in the high-resolution cASIC1 structure (rmsd of 0.5-0.7 Å over 416-420 residues, depending on the chain), which is not surprising given the high level of sequence identity between the two channels (90%). The stereochemical quality of the rASIC1a model is comparable with that of the cASIC1 templates (see Supplementary Table S1 ).
Blind docking of our refined π-TRTX-Pc1a structure onto the homology model of rASIC1a
confirmed that the toxin binds to the acidic pocket of the channel as shown previously (Pietra, 2009; Qadri et al., 2009) . In order to refine the molecular details of this interaction, ambiguous interaction restraints derived from the mutagenesis studies were then used to drive This article has not been copyedited and formatted. The final version may differ from this version. the docking of π-TRTX-Pc1a onto the model of rASIC1a using HADDOCK. Residues W24, R26 and R27 of π-TRTX-Pc1a were defined as "active" AIRs based on mutagenesis experiments. In addition, the backbone and sidechains of toxin residues 24-29 were allowed to be flexible during the final stages of docking due to the significant molecular motion observed for these residues in NMR relaxation/dispersion experiments and MD simulations.
Very few studies have examined which residues on ASIC1a are required for interaction with π-TRTX-Pc1a. However, a point mutant of D349 near the centre of the proton-binding pocket was previously shown to decrease inhibition of ASIC1a by π-TRTX-Pc1a (Salinas et al., 2006 ). This residue is adjacent to residues 167-185 on the neighboring subunit that were shown to be critical for binding of π-TRTX-Pc1a (Chen et al., 2006) . Thus, in order to define a set of active AIRs on the channel, a point in the centre of the acidic pocket was chosen and all residues within a 10 Å radius of this site with more than 30% solvent accessibility in the rASIC1a model were defined as AIRs (see Supplementary Fig. S4 ). All active residues on the channel were allowed to be semi-flexible during docking.
In all of the top 200 water-refined solutions, π-TRTX-Pc1a docked to the same region of the channel, with loop 4 at the "tip" of the triangular-shaped toxin sandwiched in the acidic pocket between adjacent subunits (Fig. 8A) . Furthermore, the various poses differ only by rotations around the functional tip of the toxin relative to the lowest energy structure (Fig. 8B) . Despite this rotation, the key functional residues in loop 4 (particularly W24-R28) localize to the same site on the channel and overlay remarkably well. Thus, for the sake of clarity, the following discussion will focus on the top 10 solutions from the lowest energy cluster (i.e., the cluster with the lowest HADDOCK scores) (Fig. 8C ).
This article has not been copyedited and formatted. The final version may differ from this version. The mean buried interface area in the top ten structures (2000 ± 40 Å) was slightly higher than the average buried surface area of 1600 ± 400 Å for all protein-protein complexes in the PDB (Dominguez et al., 2003) . Table 2 summarizes the observed hydrogen bond and nonbonded interactions in the top 10 poses, and the key interactions are shown schematically in Fig. 9 . The interaction between the toxin and the channel is dominated by ionic interactions and, as anticipated, each of the three residues in loop 4 that cause a major reduction in π-TRTX-Pc1a activity when mutated to Ala (i.e., W24, R26, and R27) make significant contributions. The positively charged guanidino group of R26 forms an ion pair with the carboxyl group of D237 while the sidechain amide proton of R26 forms a hydrogen bond with the carboxyl group of E235 (Fig. 9B) . The guanidino group of R27 makes ionic interactions with the carboxyl groups of both E242 on subunit A of the channel and D407 on subunit C (Fig. 9C) . The sidechain amide group of W24 forms a hydrogen bond with the sidechain carboxyl group of D349 (Fig. 9A ). This latter interaction presumably explains why mutation of D349 decreases the ability of π-TRTX-Pc1a to inhibit ASIC1a (Salinas et al., 2006) .
It was previously shown that π-TRTX-Pc1a modulation of human ASIC1a is completely abolished by a F352L mutation ). However, even though the corresponding F350 residue in rASIC1a was included as an active restraint in the HADDOCK docking, we never observed an interaction between this channel residue and the toxin. The sidechain of this residue points away from the acidic pocket in both the crystal structure of cASIC1 and the homology model of rASIC1a and therefore is not in a position to interact with the toxin. Moreover, the F352L mutation in human ASIC1a causes an acidic shift in the pH dependence of channel activation , suggesting that the channel conformation/gating mechanism is perturbed. Thus, we propose that mutation of F352 to Leu abrogates the binding of π-TRTX-Pc1a to human ASIC1a is because it perturbs the This article has not been copyedited and formatted. The final version may differ from this version. conformation of the helix in which it resides, thus altering the spatial disposition of the adjacent D349 and P346 residues that are required for interaction with toxin residue Trp24.
While the interactions between W24, R26 and R27 and residues on the channel are conserved in all low-energy clusters in the final docking solutions, the sidechain of K25 does not make any consistent interaction with the channel. Although K25 interacts with channel residues D349 and E353 in the lowest-energy cluster, in most clusters it points away from the channel towards the solvent (see Supplementary Fig. S5 ). This is consistent with our data showing that mutation of K25 to Ala does not reduce the ability of π-TRTX-Pc1a to inhibit ASIC1a.
Notably, W24, R26, and R27 mostly interact with the same subunit of the channel (defined as subunit A in the current model). In contrast, although R28 was not included as an active AIR, the sidechain of this toxin residue forms an ion pair with the carboxylate group of E219 on the adjacent subunit of the channel (subunit C in the current model) (Fig. 9D) , implicating R28 as part of the toxin pharmacophore. We consequently predict that mutagenesis of R28 to virtually any other residue, with the possible exception of His and Lys, will impair toxin binding and activity. Other loop 4 residues that were identified from the docking as likely to be important for the interaction include S29 and E31 (see Table 2 and Fig. 9E-F) . C-terminal residues K36, T37, K39 and T40 also make favorable contacts with the channel (summarized in Table 2 and Fig. 9G-H ).
Numerous residues from the adjacent subunit C interact with the toxin (see Table 2 ). Most of these residues are conserved across all ASIC subtypes with H173 and A178 being the notable exceptions (Fig. 9I ). H173 appears to play a major role in π-TRTX-Pc1a binding as it interacts with three toxin residues (R27, R28, and S29; see Table 2 ) and makes more This article has not been copyedited and formatted. The final version may differ from this version. intermolecular contacts than any other residue in subunit C. Since H173 and A178 are present only in ASIC1a, we propose that they play a key role in determining the ability of π-TRTX-Pc1a to specifically block homomeric ASIC1a channels, but not other homomeric or heteromeric ASIC channels.
Discussion
The tarantula toxin π-TRTX-Pc1a is the most potent and selective blocker of ASIC1a discovered to date. It has a unique mechanism of action, shifting the steady-state desensitization of ASIC1a to more alkaline pH and rendering the channel inactive at physiological proton concentrations (Chen et al., 2005) . Since ASIC1a is now recognized as a novel and broad ranging therapeutic target, understanding the molecular basis of its interaction with π-TRTX-Pc1a should aid the rational development of potential analgesics and neuroprotective drugs that target this channel. The recent determination of the crystal structure of chicken ASIC1 (Jasti et al., 2007; Gonzales et al., 2009 ) has opened up the possibility of using molecular docking studies to gain insight into this interaction. These crystal structures were determined at low pH and likely represent the desensitized state of the channel. This is fortuitous, as π-TRTX-Pc1a is believed to bind with higher affinity to the desensitized state of ASIC1a than either the closed or open state (Chen et al., 2006) .
The interaction between π-TRTX-Pc1a and a model of hASIC1a based on the cASIC1 structure was investigated in two previous docking studies (Pietra, 2009; Qadri et al., 2009 ) in which no experimental restraints were used to guide the docking. The toxin was found to bind to the same site on hASIC1a (i.e., the acidic pocket) in both studies, but in different orientations. Consequently, no definitive molecular model is currently available to guide drug development studies. We reasoned that molecular docking based on experimental restraints This article has not been copyedited and formatted. The final version may differ from this version. should produce a more reliable model for rational design of ASIC1a blockers.
To this end, we developed an efficient bacterial system for production of recombinant π-TRTX-Pc1a that allowed us to: (i) determine a higher quality structure of the toxin; (ii) examine its solution dynamics; and (iii) use a panel of point mutants to define key components of the toxin pharmacophore. While the new structure of π-TRTX-Pc1a is very precise and of high stereochemical quality, it appeared to show disorder in the β-hairpin loop (loop 4) containing key pharmacophore residues. We used a combination of MD simulations, NMR spin relaxation experiments, and NMR relaxation dispersion measurements to show that there is significant motion in the pharmacophore loop over a wide range of timescales (ps to µs; see Figs 6 and 7), supporting the apparent lack of precision for loop 4 residues in the NMR-derived toxin structure. Although the sidechains of these residues are likely to be more rigid when the toxin binds to ASIC1a, it is critical that their intrinsic flexibility is taken into account in docking studies in order to prevent the formation of a structurally nonphysiological complex. While a structure of π-TRTX-Pc1a bound to ASIC1a would be undoubtedly beneficial for rational structure-based design of mimetics that mimic the action of the toxin, understanding the conformational states that the peptide can access may also aid the design of mimetics.
Defining the π-TRTX-Pc1a pharmacophore
We used a panel of point mutants to demonstrate that W24, R26 and R27 in loop 4 are critical for the ability of π-TRTX-Pc1a to inhibit ASIC1a. It was initially surprising that mutation of K25, which is located in the middle of this positively charged loop, had no effect on the ability of the toxin to inhibit ASIC1a. However, close inspection of the new toxin structure reveals that the sidechain of K25 lies on the opposite face of the β-hairpin loop to the This article has not been copyedited and formatted. The final version may differ from this version. sidechains of W24, R26 and R27 (Fig. 5) . Moreover, in many of the final docking poses obtained for the π-TRTX-Pc1a:ASIC1a complex this residue points away from the channel, thus providing an explanation for its lack of involvement in toxin activity.
Modeling the π-TRTX-Pc1a:ASIC1a interaction There were several key differences between the ASIC1a model used in the current study and those used in previous docking studies (Pietra, 2009; Qadri et al., 2009 ). First, we used rat rather than human ASIC1a as π-TRTX-Pc1a binds more avidly to the rat channel (data not shown) and the majority of structure-activity relationship studies examining the interaction between π-TRTX-Pc1a and ASIC1a, including those reported here, used the rat channel.
Second, we incorporated explicit flexibility for interacting residues at the toxin:channel interface based on our experimental data showing that the toxin pharmacophore is dynamic.
Third, we were able to incorporate physiologically relevant protonation states for key ionizable residues in our model. Pietra used REDUCE for automatic protonation of His and Asp residues (Pietra, 2009 ), while Qadri et al. (2009) did not describe the protonation states used in their model. The pK a of His, Asp and Glu residues in ASIC1a were recently determined using a Poisson-Boltzmann continuum approach and homology models of hASIC1a (Liechti et al., 2010) and we used these values to yield the appropriate protonation states for these residues at pH 7.
We used HADDOCK for docking as it enabled the incorporation of ambiguous interaction restraints derived from mutagenesis data and movement of pharmacophore residues at the interaction interface during the simulated annealing process The latter feature was considered critical as the intrinsic flexibility of the toxin pharmacophore that was revealed in the current study precludes the use of rigid body docking. Consistent with previous docking studies This article has not been copyedited and formatted. The final version may differ from this version. (Pietra, 2009; Qadri et al., 2009 ), π-TRTX-Pc1a was found to bind to the acidic pocket of ASIC1a (i.e., one of the sites responsible for activation of the channel by protons at acidic pH). Previous mutagenesis studies led to the conclusion that domains 3 and 5 of ASIC1a (i.e., residues 157-185 and 272-369, respectively) are intimately involved in binding π-TRTX-Pc1a (Salinas et al., 2006) , and the majority of channel residues at the interaction interface in our docking model fall within these two domains.
In addition, residues from neighboring subunits were also involved in the interaction, and several of these residues (i.e., H173 and A178; see Fig. 9I ) are only present in ASIC1a; this might at least partly explain why π-TRTX-Pc1a only inhibits homomeric ASIC1a channels.
However, it is important to note that π-TRTX-Pc1a is believed to bind more tightly to the Consistent with the results from our mutagenesis experiments, the toxin residues that make the largest number of interactions with the channel in the top ten docking solutions (i.e., W24, R26, and R27) are those that have the largest impact on toxin function when mutated to Ala.
In contrast, the sidechain of K25 did not make any consistent interaction with the channel, in agreement with our data demonstrating that mutation of K25 to Ala does not reduce the ability of π-TRTX-Pc1a to inhibit ASIC1a.
A major contributor to the molecular events underlying the sensitivity of ASIC1a to acidic pH This article has not been copyedited and formatted. The final version may differ from this version. is the disruption of carboxyl-carboxylate pairs in the acidic pocket caused by the binding of protons (Jasti et al., 2007; Gründer and Chen, 2010) . We found that π-TRTX-Pc1a docks into the acidic pocket of the channel and that arginine residues from the toxin mimic the action of protons by interacting directly with several of the anionic residues in these carboxylcarboxylate pairs, including D237 and D349. Due to the sub-nanomolar affinity of π-TRTX-Pc1a for this site on the channel, we propose that the toxin effectively mimics the persistent activation by protons that leads to steady-state desensitization of ASIC1a when the extracellular pH is incrementally decreased . This is consistent with the observation that π-TRTX-Pc1a shifts the steady-state desensitization of ASIC1a to higher pH and renders the channel inactive under normal physiological conditions (pH 7.3-7.4) (Chen et al., 2006) .
In summary, our model of the ASIC1a:π-TRTX-Pc1a complex, which has been derived using a variety of complementary experimental approaches, is consistent with all currently available experimental data on the ASIC1a:π-TRTX-Pc1a interaction. This model greatly improves our understanding of the molecular details of this important interaction and it should facilitate the development of novel therapeutics that mimic the action of π-TRTX-Pc1a. This article has not been copyedited and formatted. The final version may differ from this version. Table 2 : Hydrogen bonds and non-bonded contacts that occur between π-TRTX-Pc1a and rASIC1a in at least half of the poses in the lowest energy HADDOCK cluster. 
